BR0009160A - Hiatal hernia treatment - Google Patents

Hiatal hernia treatment

Info

Publication number
BR0009160A
BR0009160A BR0009160-0A BR0009160A BR0009160A BR 0009160 A BR0009160 A BR 0009160A BR 0009160 A BR0009160 A BR 0009160A BR 0009160 A BR0009160 A BR 0009160A
Authority
BR
Brazil
Prior art keywords
treatment
hiatal hernia
hernia treatment
hiato
methylbutylamine
Prior art date
Application number
BR0009160-0A
Other languages
Portuguese (pt)
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BR0009160A publication Critical patent/BR0009160A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TRATAMENTO DE HéRNIA DE HIATO". Um composto de fórmula (I), ou seu sal farmaceuticamente aceitável, em que R~ 1~ e R~ 2~ são independentemente H ou metila (por exemplo, cloridrato de N,N-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-metilbutilamina, opcionalmente na forma de seu monoidrato) é usado para o tratamento de hérnias de hiato e esofagite de refluxo."HIATO HERNIA TREATMENT". A compound of formula (I), or its pharmaceutically acceptable salt, wherein R ~ 1 ~ and R ~ 2 ~ are independently H or methyl (for example, N, N-dimethyl-1- [1- (4- chlorophenyl) cyclobutyl] -3-methylbutylamine, optionally in the form of its monohydrate) is used for the treatment of hiatus hernias and reflux esophagitis.

BR0009160-0A 1999-03-19 2000-03-17 Hiatal hernia treatment BR0009160A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12511699P 1999-03-19 1999-03-19
PCT/US2000/007112 WO2000056307A1 (en) 1999-03-19 2000-03-17 Treatment of hiatial hernia

Publications (1)

Publication Number Publication Date
BR0009160A true BR0009160A (en) 2002-01-29

Family

ID=22418261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009160-0A BR0009160A (en) 1999-03-19 2000-03-17 Hiatal hernia treatment

Country Status (20)

Country Link
EP (1) EP1169028A1 (en)
JP (1) JP2002539249A (en)
KR (1) KR20030006909A (en)
CN (1) CN1376061A (en)
AU (1) AU3894400A (en)
BG (1) BG106000A (en)
BR (1) BR0009160A (en)
CA (1) CA2367035A1 (en)
CZ (1) CZ20013279A3 (en)
HK (1) HK1044703A1 (en)
HU (1) HUP0200498A2 (en)
IL (1) IL145242A0 (en)
MX (1) MXPA01009463A (en)
NO (1) NO20014476L (en)
NZ (1) NZ514013A (en)
PL (1) PL351081A1 (en)
SK (1) SK13392001A3 (en)
TR (1) TR200102700T2 (en)
WO (1) WO2000056307A1 (en)
ZA (1) ZA200107679B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006833B (en) * 2012-12-31 2014-02-12 代凤玲 Medicine for hiatus hernia postoperative rehabilitation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
WO2000056307A1 (en) 2000-09-28
EP1169028A1 (en) 2002-01-09
HK1044703A1 (en) 2002-11-01
JP2002539249A (en) 2002-11-19
NO20014476L (en) 2001-10-29
NO20014476D0 (en) 2001-09-14
AU3894400A (en) 2000-10-09
PL351081A1 (en) 2003-03-10
SK13392001A3 (en) 2002-04-04
NZ514013A (en) 2001-09-28
IL145242A0 (en) 2002-06-30
CA2367035A1 (en) 2000-09-28
CN1376061A (en) 2002-10-23
HUP0200498A2 (en) 2002-08-28
TR200102700T2 (en) 2002-04-22
CZ20013279A3 (en) 2002-07-17
ZA200107679B (en) 2003-06-18
MXPA01009463A (en) 2004-03-19
KR20030006909A (en) 2003-01-23
BG106000A (en) 2002-06-28

Similar Documents

Publication Publication Date Title
PH31220A (en) Medical treatment.
BR0009026A (en) Eating Disorder Treatment Method
BR0009563A (en) Biphenyl ap2 inhibitors containing heterocyclic and method
CA2119745A1 (en) Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
DE69408666D1 (en) RISPERIDON PAMOATE
NZ545506A (en) Therapeutic agents useful for treating pain
BR0113389A (en) Compounds that inhibit factor xa activity
BR9711414A (en) Pharmaceutical process and compositions for lowering the level of uric acid in the human body and for prophylaxis of gout, hyperuricemia or coronary heart disease in humans, and use of a compound
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
BR0101230A (en) Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5-5-dioxo-6-methyl-dibenzo [c, f] [1,2] thiazepine and application for the synthesis of detianeptine
WO2000056315A8 (en) Treatment of pain
BR0009160A (en) Hiatal hernia treatment
BRPI0413419A (en) composition comprising rosiglitazone and another antidiabetic agent
BR0009081A (en) Osteoarthritis Treatment
BR0111743A (en) Farnesyl transferase which inhibits 1,2-ringed quinoline enantiomer
CO5150213A1 (en) ORAL SERTRALINE CONCENTRATE
ES2126117T3 (en) CHEMICAL DISINFECTANT AGENT BASED ON ACTIVE PHENOLIC COMPONENTS AND GLUTARALDEHIDE.
EP1325918A4 (en) Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases
MXPA01009469A (en) Treatment to lower platelet adhesiveness.
SE9902268D0 (en) Pharmaceutically active compounds
ECSP034549A (en) CRYSTALLINE FORMS OF 1- (6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINIL) HYDROCHLORIDE PIPERAZINE
BR0009078A (en) Weight loss after pregnancy
WO2002044159A3 (en) 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
RU2001119804A (en) Means for inhibiting the growth of sulfate reducing bacteria
IT1317669B1 (en) INSTRUMENT FOR THE IMPLANTATION OF A SURGICAL PLATE FOR OSTEOSYNTHESIS.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]